FOLH1 and prostate cancer: It has previously been demonstrated that a type II integral membrane glycoprotein highly expressed in prostate cancer cells called ‘prostate-specific membrane antigen’ (PSMA) is also up-regulated in the neovasculature of solid tumours including RCC [10].